3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Lymphoma, Large B-Cell, Diffuse
28
Leukemia, Myeloid, Acute
27
Precursor Cell Lymphoblastic Leukemia-Lymphoma
24
Leukemia
23
Lymphoma
22
Small Cell Lung Carcinoma
20
Burkitt Lymphoma
19
Lymphoma, Non-Hodgkin
18
Lung Neoplasms
13
Recurrence
12
Neuroblastoma
12
Lymphoma, Mantle-Cell
12
Leukemia, Lymphocytic, Chronic, B-Cell
12
Congenital Abnormalities
12
Myelodysplastic Syndromes
11
Lymphoma, Follicular
11
Brain Neoplasms
10
Hodgkin Disease
9
Carcinoma, Non-Small-Cell Lung
9
Lymphoma, Large-Cell, Immunoblastic
8
Lymphoma, B-Cell, Marginal Zone
8
Leukemia, Myeloid, Accelerated Phase
8
Leukemia, Monocytic, Acute
8
Leukemia, Megakaryoblastic, Acute
8
Leukemia, Erythroblastic, Acute
8
Blast Crisis
8
Sarcoma
7
Neoplasms
7
Myeloproliferative Disorders
7
Multiple Myeloma
7
Interventions
veliparib
1
etoposide phosphate
1
binimetinib
1
Temozolomide
1
Radiotherapy
1
Radiation
1
PF-07284890
1
Midazolam
1
Etoposide
1
Dasatinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Brain Diseases
×
Etoposide
×
Clear all
NCT05762419
2026-01-28
FUS Etoposide for DMG
Columbia University
Phase 1
Recruiting
10 enrolled